Rolink AG - Search Results

1

Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome.

Cassani B, Poliani PL, Marrella V, Schena F, Sauer AV, Ravanini M, Strina D, Busse CE, Regenass S, Wardemann H, Martini A, Facchetti F, van der Burg M, Rolink AG, Vezzoni P, Grassi F, Traggiai E, Villa A. Cassani B, et al. Among authors: rolink ag. J Exp Med. 2010 Jul 5;207(7):1525-40. doi: 10.1084/jem.20091928. Epub 2010 Jun 14. J Exp Med. 2010. PMID: 20547828 Free PMC article.

2

Age-dependent changes in B lymphocyte development in man and mouse.

Ghia P, Melchers F, Rolink AG. Ghia P, et al. Among authors: rolink ag. Exp Gerontol. 2000 Mar;35(2):159-65. doi: 10.1016/s0531-5565(99)00095-9. Exp Gerontol. 2000. PMID: 10767576 Review.

3

Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.

Reininger L, Winkler TH, Kalberer CP, Jourdan M, Melchers F, Rolink AG. Reininger L, et al. Among authors: rolink ag. J Exp Med. 1996 Sep 1;184(3):853-61. doi: 10.1084/jem.184.3.853. J Exp Med. 1996. PMID: 9064345 Free PMC article.

4

Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells.

Reininger L, Radaszkiewicz T, Kosco M, Melchers F, Rolink AG. Reininger L, et al. Among authors: rolink ag. J Exp Med. 1992 Nov 1;176(5):1343-53. doi: 10.1084/jem.176.5.1343. J Exp Med. 1992. PMID: 1402680 Free PMC article.

5

Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment.

Rolink AG, Winkler T, Melchers F, Andersson J. Rolink AG, et al. J Exp Med. 2000 Jan 3;191(1):23-32. doi: 10.1084/jem.191.1.23. J Exp Med. 2000. PMID: 10620602 Free PMC article.

6

Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease.

Rolink AG, Radaszkiewicz T, Pals ST, van der Meer WG, Gleichmann E. Rolink AG, et al. J Exp Med. 1982 May 1;155(5):1501-22. doi: 10.1084/jem.155.5.1501. J Exp Med. 1982. PMID: 6461714 Free PMC article.

7

Monoclonal antibodies reactive with the mouse interleukin 5 receptor.

Rolink AG, Melchers F, Palacios R. Rolink AG, et al. J Exp Med. 1989 May 1;169(5):1693-701. doi: 10.1084/jem.169.5.1693. J Exp Med. 1989. PMID: 2469765 Free PMC article.

8

Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells.

Schaniel C, Pardali E, Sallusto F, Speletas M, Ruedl C, Shimizu T, Seidl T, Andersson J, Melchers F, Rolink AG, Sideras P. Schaniel C, et al. Among authors: rolink ag. J Exp Med. 1998 Aug 3;188(3):451-63. doi: 10.1084/jem.188.3.451. J Exp Med. 1998. PMID: 9687523 Free PMC article.

9

Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.

Rolink AG, Pals ST, Gleichmann E. Rolink AG, et al. J Exp Med. 1983 Feb 1;157(2):755-71. doi: 10.1084/jem.157.2.755. J Exp Med. 1983. PMID: 6218218 Free PMC article.

10

Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.

Van Elven EH, Rolink AG, Veen FV, Gleichmann E. Van Elven EH, et al. Among authors: rolink ag. J Exp Med. 1981 Jun 1;153(6):1474-88. doi: 10.1084/jem.153.6.1474. J Exp Med. 1981. PMID: 6454750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page